Evergreen Nephrology, LLC

Founded in 2021 by Adam Boehler and Abe Sutton and based in Tennessee, US, Evergreen Nephrology, LLC provides targeted support to nephrologists. In January 2025, Evergreen Nephrology, LLC raised USD 130 million in venture funding co-led by new investors Rubicon Founders and Oak HC/FT Partners, with participation from another new investor K2 HealthVentures. Other unspecified investors also participated in the round.  As of 2024, the company is led by its CEO, John Donlan.

Evergreen Nephrology primarily offers a technology-enabled partnership aimed at enhancing kidney care for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company provides nephrologists with financial backing and access to interdisciplinary clinical resources, analytical insights, and tools that streamline patient care. This model addresses barriers to care transformation, enabling healthcare providers to identify and manage patients requiring timely interventions. Evergreen's services are targeted at nephrologists and healthcare providers, enhancing care delivery and patient experiences in the kidney care landscape.

Evergreen Nephrology generates revenue through partnerships and strategic collaborations with nephrology practices. The business model incorporates a combination of subscription-based services and performance-based contracts aligned with quality care metrics set by organizations such as the Centers for Medicare & Medicaid Services (CMS). The organization plans to use the January 2025 funding to support its expansion plans and the development of its clinical trials.